Enya F Fullston1, Michael J Doyle1, Mary F Higgins2, Susan J Knowles3,4,5. 1. School of Medicine, University College Dublin, Dublin 4, Ireland. 2. UCD Perinatal Research Centre, University College Dublin, National Maternity Hospital, Holles Street, Dublin 2, Ireland. 3. Department of Microbiology, National Maternity Hospital, Holles Street, Dublin 2, Ireland. sknowles@nmh.ie. 4. Department of Microbiology, Royal Victoria Eye and Ear Hospital, Dublin 2, Ireland. sknowles@nmh.ie. 5. National Maternity Hospital, Holles Street, Dublin 2, Ireland. sknowles@nmh.ie.
Abstract
BACKGROUND: Early-onset group B Streptococcus (EOGBS/GBS) infection remains a significant cause of neonatal morbidity and mortality. AIMS: Aiming to improve antimicrobial stewardship and reduce unnecessary maternal and infant exposure to intrapartum antibiotic prophylaxis (IAP), this study assessed the clinical use of a commercially available GBS polymerase chain reaction (PCR) assay for term women with pre-labour rupture of membranes. METHODS: This was a retrospective study in a tertiary level maternity unit of term women with pre-labour rupture of membranes (ROM), without any clinical suspicion of infection performed between November and December 2017. GBS PCR tests were cross-referenced with patient clinical data. PCR test results, the impact of testing on antibiotic administration, pyrexia in labour, induction, interventional delivery rates and neonatal outcomes were analysed. RESULTS: Of 200 patients included in the study, 29 were positive (14.5%) and 166 were negative (83%), with five invalid results (2.5%). One hundred and twenty three women had > 18-h ruptured membranes and 86 women (70%) who would have been eligible for IAP based on risk factors avoided antibiotic therapy following a negative PCR test. There were no significant differences in induction or interventional delivery rates between GBS-positive and GBS-negative women following PCR testing. During the study period, there were no cases of EOGBS. CONCLUSIONS: In a centre adhering to a risk-factor-based GBS policy, the introduction of limited rapid GBS screening for term women with pre-labour rupture of membranes resulted in a clinically significant reduction in prophylactic antibiotic use.
BACKGROUND: Early-onset group B Streptococcus (EOGBS/GBS) infection remains a significant cause of neonatal morbidity and mortality. AIMS: Aiming to improve antimicrobial stewardship and reduce unnecessary maternal and infant exposure to intrapartum antibiotic prophylaxis (IAP), this study assessed the clinical use of a commercially available GBS polymerase chain reaction (PCR) assay for term women with pre-labour rupture of membranes. METHODS: This was a retrospective study in a tertiary level maternity unit of term women with pre-labour rupture of membranes (ROM), without any clinical suspicion of infection performed between November and December 2017. GBS PCR tests were cross-referenced with patient clinical data. PCR test results, the impact of testing on antibiotic administration, pyrexia in labour, induction, interventional delivery rates and neonatal outcomes were analysed. RESULTS: Of 200 patients included in the study, 29 were positive (14.5%) and 166 were negative (83%), with five invalid results (2.5%). One hundred and twenty three women had > 18-h ruptured membranes and 86 women (70%) who would have been eligible for IAP based on risk factors avoided antibiotic therapy following a negative PCR test. There were no significant differences in induction or interventional delivery rates between GBS-positive and GBS-negative women following PCR testing. During the study period, there were no cases of EOGBS. CONCLUSIONS: In a centre adhering to a risk-factor-based GBS policy, the introduction of limited rapid GBS screening for term women with pre-labour rupture of membranes resulted in a clinically significant reduction in prophylactic antibiotic use.
Entities:
Keywords:
GBS; GeneXpert®; PCR; Term pre-labour ROM
Authors: E Poncelet-Jasserand; F Forges; M-N Varlet; C Chauleur; P Seffert; C Siani; B Pozzetto; A Ros Journal: BJOG Date: 2013-05-08 Impact factor: 6.531
Authors: Martin Mueller; Ariane Henle; Sara Droz; Andre B Kind; Susanne Rohner; Marc Baumann; Daniel Surbek Journal: Eur J Obstet Gynecol Reprod Biol Date: 2014-03-12 Impact factor: 2.435
Authors: Yuri Perlitz; Moshe Ben-Ami; Emanuel C Megory; Orna Nitzan; Tal Bouganim; Johnny S Younis; Nora Shapso; Avi Peretz Journal: J Matern Fetal Neonatal Med Date: 2017-08-06
Authors: Karen M Edmond; Christina Kortsalioudaki; Susana Scott; Stephanie J Schrag; Anita K M Zaidi; Simon Cousens; Paul T Heath Journal: Lancet Date: 2012-01-04 Impact factor: 79.321